This website is for all pediatric chronic disease, and not specific to rheumatology. The website focuses on provider education and outlines core elements of transition. These elements include transitioning youth to adult health care providers, transition to an adult approach to health care without changing providers, and integrating young adults into adult health care. There are tools available to assess the pediatric patient’s readiness for transition. There are also resources for policymakers and research. This website is focused on care in the USA.
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences